Momenta Pharmaceuticals

MNTA

MNTA
Momenta Pharmaceuticals Stock Quote
$13.21 -$0.70 -5.0%
BATS BZX Real Time Price as of May 17, 2019, 4:30 p.m. View Interactive MNTA Charts

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

News & Analysis: Momenta Pharmaceuticals

The Fool has written over 100 articles on Momenta Pharmaceuticals.

All

Market Moves

Earnings







Momenta Moves On

The biotech is shifting focus away from biosimilars and toward its pipeline of immune drugs.





Interactive Chart